Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Total 13F shares
-
80,446,457
-
Share change
-
+2,084,154
-
Total reported value
-
$3,272,347,185
-
Put/Call ratio
-
28%
-
Price per share
-
$40.67
-
Number of holders
-
199
-
Value change
-
+$72,106,478
-
Number of buys
-
113
-
Number of sells
-
91
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2023
As of 30 Jun 2023,
PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by
199 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,446,457 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, RTW INVESTMENTS, LP, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, FRANKLIN RESOURCES INC, ARMISTICE CAPITAL, LLC, STATE STREET CORP, and Camber Capital Management LP.
This page lists
201
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.